{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:30:39Z","timestamp":1780486239283,"version":"3.54.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["SBI-167982"],"award-info":[{"award-number":["SBI-167982"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jacadv.2023.100309","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T14:37:41Z","timestamp":1682519861000},"page":"100309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Homozygous Familial Hypercholesterolemia in Canada"],"prefix":"10.1016","volume":"2","author":[{"given":"Leslie","family":"Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Ruel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Baass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Bergeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam R.","family":"Brunham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubomira","family":"Cermakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Couture","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Gaudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon A.","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Hegele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iulia","family":"Iatan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.B. John","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian W.","family":"McCrindle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ransom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark H.","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"McPherson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Genest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacadv.2023.100309_bib1","series-title":"Orphanet report series: prevalence, incidence or reported number of published cases listed in alphabetical order of disease","author":"Consortium","year":"2022"},{"issue":"2","key":"10.1016\/j.jacadv.2023.100309_bib2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/01.ATV.9.2.211","article-title":"Homozygous familial hypercholesterolemia among French Canadians in Quebec Province","volume":"9","author":"Moorjani","year":"1989","journal-title":"Arteriosclerosis"},{"issue":"10","key":"10.1016\/j.jacadv.2023.100309_bib3","first-page":"2508","article-title":"Phenotypical, clinical, and molecular aspects of adults and children with homozygous familial hypercholesterolemia in iberoamerica","volume":"40","author":"Alves","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"32","key":"10.1016\/j.jacadv.2023.100309_bib4","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1093\/eurheartj\/ehu274","article-title":"Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society","volume":"35","author":"Cuchel","year":"2014","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.jacadv.2023.100309_bib5","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/MOL.0000000000000686","article-title":"Evidence for improved survival with treatment of homozygous familial hypercholesterolemia","volume":"31","author":"Belanger","year":"2020","journal-title":"Curr Opin Lipidol"},{"issue":"1","key":"10.1016\/j.jacadv.2023.100309_bib6","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.atherosclerosis.2015.09.029","article-title":"Improved cardiovascular outcomes following temporal advances in lipid-lowering therapy in a genetically-characterised cohort of familial hypercholesterolaemia homozygotes","volume":"243","author":"Thompson","year":"2015","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.jacadv.2023.100309_bib7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/hrt.44.4.361","article-title":"Cadiovascular complications of homozygous familial hypercholesterolaemia","volume":"44","author":"Allen","year":"1980","journal-title":"Br Heart J"},{"issue":"2","key":"10.1016\/j.jacadv.2023.100309_bib8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1017\/S1047951102000240","article-title":"Impact of the characteristics of patients and their clinical management on outcomes in children with homozygous familial hypercholesterolemia","volume":"12","author":"Al-Shaikh","year":"2002","journal-title":"Cardiol Young"},{"issue":"11","key":"10.1016\/j.jacadv.2023.100309_bib9","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.amjcard.2008.07.035","article-title":"Longitudinal evaluation and assessment of cardiovascular disease in patients with homozygous familial hypercholesterolemia","volume":"102","author":"Kolansky","year":"2008","journal-title":"Am J Cardiol"},{"issue":"12","key":"10.1016\/j.jacadv.2023.100309_bib10","first-page":"1553","article-title":"Canadian Cardiovascular Society position statement on familial hypercholesterolemia: update 2018","volume":"34","author":"Brunham","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacadv.2023.100309_bib11","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.atherosclerosis.2018.05.040","article-title":"Familial hypercholesterolemia in Canada: initial results from the FH Canada National Registry","volume":"277","author":"Brunham","year":"2018","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.jacadv.2023.100309_bib12","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1161\/ATVBAHA.107.160408","article-title":"Vascular calcifications in homozygote familial hypercholesterolemia","volume":"28","author":"Awan","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"10.1016\/j.jacadv.2023.100309_bib13","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/gim.2017.151","article-title":"Analysis of publicly available LDLR, APOB, and PCSK9 variants associated with familial hypercholesterolemia: application of ACMG guidelines and implications for familial hypercholesterolemia diagnosis","volume":"20","author":"Chora","year":"2018","journal-title":"Genet Med"},{"key":"10.1016\/j.jacadv.2023.100309_bib14","doi-asserted-by":"crossref","unstructured":"Brown L, Ruel I, Baass A et\u00a0al Design, rationale and preliminary results of the Canadian homozygous familial hypercholesterolemia - HoFH registry (2008 \u2013 2022 update). Can J Health Tech. Published online February 10, 2023. https:\/\/doi.org\/10.51731\/cjht.2023.572","DOI":"10.51731\/cjht.2023.572"},{"issue":"14","key":"10.1016\/j.jacadv.2023.100309_bib15","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/eurheartj\/ehx317","article-title":"Survival in homozygous familial hypercholesterolaemia is determined by the on-treatment level of serum cholesterol","volume":"39","author":"Thompson","year":"2018","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.jacadv.2023.100309_bib16","first-page":"1419.e1","article-title":"The lifelong burden of homozygous familial hypercholesterolemia","volume":"35","author":"Banerjee","year":"2019","journal-title":"Can J Cardiol"},{"issue":"20","key":"10.1016\/j.jacadv.2023.100309_bib17","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1161\/CIRCULATIONAHA.111.042523","article-title":"Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid-lowering therapy","volume":"124","author":"Raal","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2023.100309_bib18","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.atherosclerosis.2018.06.859","article-title":"Familial hypercholesterolemia treatments: guidelines and new therapies","volume":"277","author":"Raal","year":"2018","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.jacadv.2023.100309_bib19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1744-9987.2008.00574.x","article-title":"Low-density lipoprotein apheresis in children with familial hypercholesterolemia: follow-up to 21 years","volume":"12","author":"Palcoux","year":"2008","journal-title":"Ther Apher Dial"},{"issue":"5","key":"10.1016\/j.jacadv.2023.100309_bib20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1567-5688(09)71805-7","article-title":"LDL-apheresis in homozygous LDL-receptor-defective familial hypercholesterolemia: the Munich experience","volume":"10","author":"Keller","year":"2009","journal-title":"Atheroscler Suppl"},{"issue":"3","key":"10.1016\/j.jacadv.2023.100309_bib21","first-page":"409","article-title":"Barriers to the implementation of lipoprotein apheresis in Canada","volume":"33","author":"Filler","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacadv.2023.100309_bib22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.atherosclerosis.2020.07.028","article-title":"Lomitapide for treatment of homozygous familial hypercholesterolemia: the Quebec experience","volume":"310","author":"Aljenedil","year":"2020","journal-title":"Atherosclerosis"},{"issue":"10326","key":"10.1016\/j.jacadv.2023.100309_bib23","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0140-6736(21)02001-8","article-title":"Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study","volume":"399","author":"Tromp","year":"2022","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jacadv.2023.100309_bib24","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1136\/hrt.50.5.432","article-title":"Cross sectional echocardiographic assessment of the aortic root and coronary ostial stenosis in familial hypercholesterolaemia","volume":"50","author":"Ribeiro","year":"1983","journal-title":"Br Heart J"},{"key":"10.1016\/j.jacadv.2023.100309_bib25","doi-asserted-by":"crossref","first-page":"3685265","DOI":"10.1155\/2017\/3685265","article-title":"Premature valvular heart disease in homozygous familial hypercholesterolemia","volume":"2017","author":"Fahed","year":"2017","journal-title":"Cholesterol"},{"issue":"6","key":"10.1016\/j.jacadv.2023.100309_bib26","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1136\/hrt.80.6.583","article-title":"Extent and severity of atherosclerotic involvement of the aortic valve and root in familial hypercholesterolaemia","volume":"80","author":"Rallidis","year":"1998","journal-title":"Heart"},{"issue":"34","key":"10.1016\/j.jacadv.2023.100309_bib27","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehac339","article-title":"Aortic stenosis in homozygous familial hypercholesterolaemia: a paradigm shift over a century","volume":"43","author":"Belanger","year":"2022","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.jacadv.2023.100309_bib28","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00000658-198309000-00004","article-title":"Portacaval shunt in patients with familial hypercholesterolemia","volume":"198","author":"Starzl","year":"1983","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.jacadv.2023.100309_bib29","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.amjcard.2016.05.042","article-title":"Effects of liver transplantation on lipids and cardiovascular disease in children with homozygous familial hypercholesterolemia","volume":"118","author":"Martinez","year":"2016","journal-title":"Am J Cardiol"},{"issue":"8","key":"10.1016\/j.jacadv.2023.100309_bib30","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa2004215","article-title":"Evinacumab for homozygous familial hypercholesterolemia","volume":"383","author":"Raal","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.jacadv.2023.100309_bib31","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S2213-8587(16)30041-9","article-title":"Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel","volume":"4","author":"Santos","year":"2016","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X23000807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X23000807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T13:55:11Z","timestamp":1757426111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X23000807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S2772963X23000807"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2023.100309","relation":{},"ISSN":["2772-963X"],"issn-type":[{"value":"2772-963X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Homozygous Familial Hypercholesterolemia in Canada","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2023.100309","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"100309"}}